Specialities and Expertise:Biopharma, Biotechnology, Health Care, Medical Research, Antibody Platform, T Cell Platform, Innate Immunity Platform, siRNA Platform, Pathogens, Immune System, Global Infectious Diseases Combat, Influenza A, HIV, HBV, TB, Immunology, Immune System Enhancement.
Size and Minority Status
- Products and services 2
- Сommodity codes
VIR Biotechnology is developing VIR-2482 an Influenza A Prophylaxis to fight against influenza. It provides passive immunity to create protective influenza virus antibodies. A single dose of the vaccine has the potential to last the entire flu season
VIR-2218 is an HBV-targeting siRNA to inhibit the production of all HBV proteins, including hepatitis B virus surface antigen (HBsAg) and hypnothesized to remove the inhibition of T cell activity dorected against HBV.
Locations Served 1
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.